Hand Sanitizer (Pharmacies) - Central & Western Europe

  • Central & Western Europe
  • Revenue in the Hand Sanitizer market is projected to reach US$239.40m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 3.18%, resulting in a market volume of US$271.30m by 2028.
  • In global comparison, most revenue will be generated in China (US$385.20m in 2024).
  • In relation to total population figures, per person revenues of US$0.71 are generated in 2024.

Key regions: Japan, Germany, Europe, Australia, France

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Hand Sanitizer (Pharmacies) market in Central & Western Europe has seen significant growth in recent years, driven by increasing consumer awareness of the importance of hand hygiene and the need for effective sanitization products.

Customer preferences:
Customers in Central & Western Europe have shown a strong preference for hand sanitizers that are alcohol-based, as these are considered to be more effective in killing germs and bacteria. Additionally, customers are increasingly looking for hand sanitizers that are gentle on the skin and do not cause dryness or irritation. As a result, there has been a growing demand for hand sanitizers that contain moisturizing ingredients such as aloe vera or glycerin.

Trends in the market:
One of the key trends in the Hand Sanitizer (Pharmacies) market in Central & Western Europe is the increasing demand for natural and organic hand sanitizers. Customers are becoming more conscious of the ingredients used in personal care products and are seeking out products that are free from harsh chemicals and artificial fragrances. This trend is driven by a growing interest in sustainability and a desire to minimize exposure to potentially harmful substances. Another trend in the market is the rising popularity of pocket-sized hand sanitizers. These compact and portable products are convenient for on-the-go use and have gained traction among busy professionals and frequent travelers. Additionally, there has been a shift towards hand sanitizers with innovative packaging designs that are visually appealing and stand out on store shelves.

Local special circumstances:
In some countries in Central & Western Europe, such as Germany and France, there are strict regulations governing the sale and marketing of hand sanitizers. These regulations require hand sanitizers to meet specific safety and efficacy standards, and they also restrict the use of certain ingredients. As a result, companies operating in these markets need to ensure that their products comply with the local regulations in order to gain market access.

Underlying macroeconomic factors:
The Hand Sanitizer (Pharmacies) market in Central & Western Europe is influenced by several macroeconomic factors. One of the key drivers of market growth is the increasing emphasis on healthcare and hygiene in the region. With the rising prevalence of infectious diseases and the growing awareness of the importance of hand hygiene, consumers are more willing to invest in hand sanitizers as a preventive measure. Additionally, the COVID-19 pandemic has had a significant impact on the Hand Sanitizer (Pharmacies) market in Central & Western Europe. The outbreak of the virus has led to a surge in demand for hand sanitizers, as individuals and businesses prioritize hand hygiene to prevent the spread of the virus. This increased demand has created opportunities for both established players and new entrants in the market. In conclusion, the Hand Sanitizer (Pharmacies) market in Central & Western Europe is experiencing growth due to increasing customer preferences for alcohol-based sanitizers, the demand for natural and organic products, and the popularity of pocket-sized sanitizers. Local regulations and the impact of the COVID-19 pandemic are also important factors shaping the market dynamics.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)